Generic penetration in the retail antidepressant market.
In this article, we explore the accelerated penetration of generic antidepressants in the United States market following the availability of generic citalopram and sertraline. Analysis suggests that overall, generic penetration into the antidepressant market has grown from approximately 41 percent in January 2004 to over 73 percent in January 2010. Similar trends are uncovered when branded and generic prescriptions are analyzed by specialty.
Ventimiglia
Jeffrey
J
Mr. Ventimiglia is Analyst, Strategy and Solutions, Global Customer Management, Quintiles, Inc., Durham, North Carolina.
Kalali
Amir H
AH